Shuttle Pharmaceuticals Holdings (SHPH) Equity Average (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Equity Average history runs 6 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Equity Average rose 40.21% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 40.21% YoY), while the FY2025 annual figure was $1.5 million, down 37.8% from the prior year.
• Equity Average was $2.8 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $8.0 million in Q4 2022 to a low of -$2.1 million in Q2 2022.
• Historically, Equity Average has averaged $2.9 million across 5 years, with a median of $2.8 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Equity Average tumbled 106.27% in 2024, then jumped 1072.81% in 2025.
• A 5-year view of Equity Average shows it stood at $8.0 million in 2022, then tumbled by 39.9% to $4.8 million in 2023, then sank by 106.27% to -$303112.5 in 2024, then jumped by 701.86% to $1.8 million in 2025, then soared by 53.5% to $2.8 million in 2026.
• The last three Equity Average figures came in at $2.8 million (Q1 2026), $1.8 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.